Pharmacological Treatment of Early Multiple Sclerosis

[1]  Ludwig Kappos,et al.  Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study , 2007, The Lancet.

[2]  Pablo Villoslada,et al.  Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS , 2007, Neurology.

[3]  Moses Rodriguez,et al.  MRI findings in benign multiple sclerosis are variable , 2007, Journal of Neurology.

[4]  H. Tremlett,et al.  Longitudinal follow-up of “benign” multiple sclerosis at 20 years , 2007, Neurology.

[5]  David H Laidlaw,et al.  Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome , 2006, Journal of magnetic resonance imaging : JMRI.

[6]  J. De Keyser,et al.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.

[7]  H P Hartung,et al.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.

[8]  R. Zivadinov,et al.  Optical coherence tomography in multiple sclerosis , 2006, The Lancet Neurology.

[9]  D. Goodin.  IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event , 2006, Neurology.

[10]  M. Battaglini,et al.  Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. , 2006, Brain : a journal of neurology.

[11]  H. Brønnum-Hansen,et al.  Survival and mortality rates among Danes with MS. , 2006, International MS journal.

[12]  D. Arnold,et al.  IM interferon β-1a delays definite multiple sclerosis 5 years after a first demyelinating event , 2006, Neurology.

[13]  G. Comi,et al.  Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution , 2005, Neurology.

[14]  K. Tyler,et al.  Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. , 2005, The New England journal of medicine.

[15]  S. Atlas,et al.  Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. , 2005, The New England journal of medicine.

[16]  Marco Rovaris,et al.  Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. , 2005, Archives of neurology.

[17]  Marco Rovaris,et al.  Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. , 2005, Archives of neurology.

[18]  A J Thompson,et al.  Gray and white matter volume changes in early RRMS , 2005, Neurology.

[19]  B. Weinshenker,et al.  Natural history of multiple sclerosis. , 2005, Neurologic clinics.

[20]  M. Rovaris,et al.  An MT MRI study of the cervical cord in clinically isolated syndromes suggestive of MS , 2004, Neurology.

[21]  John Noseworthy,et al.  Clinical implications of benign multiple sclerosis: A 20‐year population‐based follow‐up study , 2004, Annals of neurology.

[22]  Rohit Bakshi,et al.  Central Nervous System Atrophy and Clinical Status in Multiple Sclerosis , 2004, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[23]  G. Barker,et al.  Evidence for grey matter MTR abnormality in minimally disabled patients with early relapsing-remitting multiple sclerosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  A. Thompson,et al.  Elevated white matter myo-inositol in clinically isolated syndromes suggestive of multiple sclerosis. , 2004, Brain : a journal of neurology.

[25]  David H. Miller,et al.  Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. , 2004, Brain : a journal of neurology.

[26]  R. Grossman,et al.  Neuronal cell injury precedes brain atrophy in multiple sclerosis , 2004, Neurology.

[27]  C. Polman,et al.  Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. , 2004, Archives of neurology.

[28]  F. Lublin,et al.  Effect of relapses on development of residual deficit in multiple sclerosis , 2003, Neurology.

[29]  F. Barkhof,et al.  Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a , 2003, Annals of neurology.

[30]  A. Thompson,et al.  New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes , 2003, Annals of neurology.

[31]  M Rovaris,et al.  Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.

[32]  J Sastre-Garriga,et al.  New diagnostic criteria for multiple sclerosis , 2003, Neurology.

[33]  F. Barkhof,et al.  Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of the disease subtype. , 2002, Archives of neurology.

[34]  P Kapeller,et al.  Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. , 2002, Brain : a journal of neurology.

[35]  L. Steinman,et al.  Approved and Future Pharmacotherapy for Multiple Sclerosis , 2002, The neurologist.

[36]  Nick C Fox,et al.  Progressive ventricular enlargement in patients with clinically isolated syndromes is associated with the early development of multiple sclerosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[37]  G. Barker,et al.  Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS , 2002, Neurology.

[38]  David H. Miller,et al.  Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis , 2002, Annals of neurology.

[39]  A. Thompson,et al.  Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis , 2002, Multiple sclerosis.

[40]  David H. Miller,et al.  A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. , 2002, The New England journal of medicine.

[41]  Jayaram K. Udupa,et al.  Magnetization Transfer Ratio Histogram Analysis of Normal-Appearing Gray Matter and Normal-Appearing White Matter in Multiple Sclerosis , 2002, Journal of computer assisted tomography.

[42]  G. Comi,et al.  In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. , 2001, Brain : a journal of neurology.

[43]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[44]  Richard A. C. Hughes,et al.  PRISMS-4: Long-term efficacy of interferon-&bgr;-1a in relapsing MS , 2001, Neurology.

[45]  G Cazzato,et al.  A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[46]  Marco Rovaris,et al.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.

[47]  G. Comi,et al.  Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.

[48]  M Cercignani,et al.  Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis , 2001, Journal of neurology, neurosurgery, and psychiatry.

[49]  J K Udupa,et al.  Magnetization transfer ratio histogram analysis of gray matter in relapsing-remitting multiple sclerosis. , 2001, AJNR. American journal of neuroradiology.

[50]  M. Rovaris,et al.  Relative contributions of brain and cervical cord pathology to multiple sclerosis disability: a study with magnetisation transfer ratio histogram analysis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[51]  C Confavreux,et al.  Relapses and progression of disability in multiple sclerosis. , 2000, The New England journal of medicine.

[52]  G. Comi,et al.  Magnetization transfer imaging to monitor the evolution of MS , 2000, Neurology.

[53]  J H Simon,et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.

[54]  G. Comi,et al.  Prognostic value of MR and magnetization transfer imaging findings in patients with clinically isolated syndromes suggestive of multiple sclerosis at presentation. , 2000, AJNR. American journal of neuroradiology.

[55]  M. Horsfield,et al.  A conventional and magnetization transfer MRI study of the cervical cord in patients with MS , 2000, Neurology.

[56]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[57]  M Filippi,et al.  Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI , 1999, Neurology.

[58]  G. Ebers,et al.  Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis , 1998, The Lancet.

[59]  A. Compston.  Genetic epidemiology of multiple sclerosis. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[60]  G. Karabatsos,et al.  Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument , 1996, Neurology.

[61]  G. Ebers.  Genetic epidemiology of multiple sclerosis , 1996, Epidemiologic reviews.

[62]  A. Sadovnick,et al.  Genetic epidemiology of multiple sclerosis: A survey , 1994, Annals of neurology.

[63]  W. Mcdonald,et al.  British Isles survey of multiple sclerosis in twins: MRI. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[64]  L. Kurland,et al.  Impairment, disability, and handicap in multiple sclerosis , 1994, Neurology.

[65]  D. Paty,et al.  Life expectancy in patients attending multiple sclerosis clinics , 1992, Neurology.

[66]  B. Ford,et al.  Long‐term follow‐up of acute partial transverse myelopathy , 1992, Neurology.

[67]  G. Comi,et al.  Paraclinical tests in acute‐onset optic neuritis: basal data and results of a short follow‐up , 1991, Acta neurologica Scandinavica.

[68]  B. Stigsby,et al.  MRI, VEP, SEP and biothesiometry suggest monosymptomatic acute optic neuritis to be a first manifestation of multiple sclerosis , 1991, Acta neurologica Scandinavica.

[69]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. , 1989, Brain : a journal of neurology.

[70]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[71]  J. Kaprio,et al.  Genetic Susceptibility to Multiple Sclerosis: A Co-twin Study of a Nationwide Series , 1988 .

[72]  P. Sandercock,et al.  Magnetic resonance imaging in isolated noncompressive spinal cord syndromes , 1987, Annals of neurology.

[73]  B E Kendall,et al.  The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. , 1987, Brain : a journal of neurology.

[74]  A. Sadun.  Silent brain lesions in patients with isolated idiopathic optic neuritis , 1987 .

[75]  I. Ormerod.  ORIGIN OF ABNORMAL MAGNETIC RESONANCE IMAGING SIGNAL IN MULTIPLE SCLEROSIS , 1986, The Lancet.

[76]  L. Jacobs,et al.  Silent brain lesions in patients with isolated idiopathic optic neuritis. A clinical and nuclear magnetic resonance imaging study. , 1986, Archives of neurology.

[77]  R. Kakigi,et al.  Disseminated lesions at presentation in patients with optic neuritis. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[78]  D. McFarlin,et al.  Oligoclonal bands in CSF , 1984, Neurology.

[79]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[80]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[81]  R. Callon,et al.  Liver injury associated with the beta-interferons for MS. , 2004, Neurology.